Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. Verlingue, L.; Hollebecque, A.; Lacroix, L.; Postel-Vinay, S.; Varga, A.; El Dakdouki, Y.; Baldini, C.; Balheda, R.; Gazzah, A.; Michot, J. M.; Marabelle, A.; Mir, O.; Arnedos, M.; Rouleau, E.; Solary, E.; De Baere, T.; Angevin, E.; Armand, J. P.; Michiels, S.; André, F.; Deutsch, E.; Scoazec, J. Y.; Soria, J. C.; Massard, C.. Eur J Cancer. 2018; 1-10: p.1-10. doi:10.1016/j.ejca.2017.12.020Article
Oncostat